Diabetes and nephrolithiasis

Current Diabetes Reports

Volumn 7, Issue 6, 2007, Pages 443-448

  Daudon, Michel ^a   Jungers, Paul ^b  

^a HÔPITAL NECKER ENFANTS MALADES   (France)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

AGE; BODY MASS; CALCIUM OXALATE STONE; CALCIUM STONE; DIABETES MELLITUS; DISEASE ASSOCIATION; ENVIRONMENTAL FACTOR; HEREDITY; HUMAN; HYPERTENSION; HYPERURICEMIA; INCIDENCE; INSULIN RESISTANCE; METABOLIC SYNDROME X; NEPHROLITHIASIS; NON INSULIN DEPENDENT DIABETES MELLITUS; OBESITY; PATHOGENESIS; PREVALENCE; REVIEW; RISK FACTOR; URIC ACID STONE; URINE PH;

DIABETES MELLITUS, TYPE 2; HUMANS; INSULIN RESISTANCE; NEPHROLITHIASIS; PREVALENCE; URIC ACID;

EID: 37349077953     PISSN: 15344827     EISSN: None     Source Type: Journal    
DOI: 10.1007/s11892-007-0075-6     Document Type: Review

References (51)

1. Stumvoll M, Goldstein BJ, van Haeften TW: Type 2 diabetes: principles of pathogenesis and therapy. Lancet 2005, 365:1333-1346.
2. Mokdad AH, Ford ES, Bowman BA, et al.: Prevalence of obesity, diabetes, and obesity-related health risk factors, 2001. JAMA 2003, 289:76-79.
3. Ford ES, Giles WH, Dietz WH: Prevalence of the metabolic syndrome among US adults: findings from the third National Health and Nutrition Examination Survey. JAMA 2002, 287:356-359.
4. Eckel RH, Grundy SM, Zimmet PZ: The metabolic syndrome. Lancet 2005, 365:1415-1428.
5. Trinchieri A, Coppi F, Montanari E, et al.: Increase in the prevalence of symptomatic upper urinary tract stones during the last ten years. Eur Urol 2000, 37:23-25.
6. Stamatelou KK, Francis ME, Jones CA, et al.: Time trends in reported prevalence of kidney stones in the United States: 1976-1994. Kidney Int 2003, 63:1817-1823.
7. Nielsen SJ, Popkin BM: Patterns and trends in food portion sizes, 1977-1998. JAMA 2003, 289:450-453.
8. Despres JP: Our passive lifestyle, our toxic diet, and the atherogenic/diabetogenic metabolic syndrome: can we afford to be sedentary and unfit? Circulation 2005, 112:453-455.
9. Taylor EN, Stampfer MJ, Curhan GC: Obesity, weight gain, and the risk of kidney stones. JAMA 2005, 293:455-462.
10. Daudon M, Dore JC, Jungers P, Lacour B: Changes in stone composition according to age and gender of patients: a multivariate epidemiological approach. Urol Res 2004, 32:241-247.
11. Hall WD, Pettinger M, Oberman A, et al.: Risk factors for kidney stones in older women in the southern United States. Am J Med Sci 2001, 322:12-18.
12. Curhan GC, Willett WC, Rimm EB, et al.: Body size and risk of kidney stones. J Am Soc Nephrol 1998, 9:1645-1652.
13. Meydan N, Barutca S, Caliskan S, Camsari T: Urinary stone disease in diabetes mellitus. Scand J Urol Nephrol 2003, 37:64-70.
14. Taylor EN, Stampfer MJ, Curhan GC: Diabetes mellitus and the risk of nephrolithiasis. Kidney Int 2005, 68:1230-1235.
15. Lieske JC, de la Vega LS, Gettman MT, et al.: Diabetes mellitus and the risk of urinary tract stones: a population-based case-control study. Am J Kidney Dis 2006, 48:897-904.
16. Sakhaee K, Adams-Huet B, Moe OW, Pak CY: Pathophysiologic basis for normouricosuric uric acid nephrolithiasis. Kidney Int 2002, 62:971-979.
17. Pak CY, Sakhaee K, Moe O, et al.: Biochemical profile of stone-forming patients with diabetes mellitus. Urology 2003, 61:523-527.
18. Daudon M, Traxer O, Conort P, et al.: Type 2 diabetes increases the risk for uric acid stones. J Am Soc Nephrol 2006, 17:2026-2033.
19. Daudon M, Lacour B, Jungers P: Influence of body size on urinary stone composition in men and women. Urol Res 2006, 34:193-199.
20. Ekeruo WO, Tan YH, Young MD, et al.: Metabolic risk factors and the impact of medical therapy on the management of nephrolithiasis in obese patients. J Urol 2004, 172:159-163.
21. Gutman AB, Yu TF: Uric acid nephrolithiasis. Am J Med 1968, 45:756-779.
22. Khatchadourian J, Preminger GM, Whitson PA, et al.: Clinical and biochemical presentation of gouty diathesis: comparison of uric acid versus pure calcium stone formation. J Urol 1995, 154:1665-1669.
23. Pak CY, Sakhaee K, Peterson RD, et al.: Biochemical profile of idiopathic uric acid nephrolithiasis. Kidney Int 2001, 60:757-761.
24. Pak CY, Poindexter JR, Peterson RD, et al.: Biochemical distinction between hyperuricosuric calcium urolithiasis and gouty diathesis. Urology 2002, 60:789-794.
25. Kamel KS, Cheema-Dhadli S, Halperin ML: Studies on the pathophysiology of the low urine pH in patients with uric acid stones. Kidney Int 2002, 61:988-994.
26. Cameron MA, Maalouf NM, Adams-Huet B, et al.: Urine composition in type 2 diabetes: predisposition to uric acid nephrolithiasis. J Am Soc Nephrol 2006, 17: 1422-1428.
27. Gutman A, Yu TF: Urine NH4+ excretion in primary gout. J Clin Invest 1965, 44:1474-1481.
28. Abate N, Chandalia M, Cabo-Chan AV Jr, et al.: The metabolic syndrome and uric acid nephrolithiasis: novel features of renal manifestation of insulin resistance. Kidney Int 2004, 65:386-392.
29. Beck-Nielsen H, Groop LC: Metabolic and genetic characterization of prediabetic states. Sequence of events leading to non-insulin-dependent diabetes mellitus. J Clin Invest 1994, 94:1714-1721.
30. Chobanian MC, Hammerman MR: Insulin-stimulated ammoniagenesis in canine renal proximal tubular segments. Am J Physiol 1987, 253:F1171-F1177.
31. Krivosikova Z, Spustova V, Dzurik R: Participation of P-dependent and P-independent glutaminases in rat kidney ammoniagenesis and their modulation by metabolic acidosis, hippurate and insulin. Physiol Res 1998, 47:177-183.
32. Klisic J, Hu MC, Nief V, et al.: Insulin activates the Na+/H+ exchanger 3 (NHE3): biphasic response and glucocorti coid dependence. Am J Physiol 2002, 283:F532-F539.
33. Nagami GT: Luminal secretion of ammonia in the mouse proximal tubule perfused in vitro. J Clin Invest 1988, 81:159-164.
34. Facchini F, Chen YD, Hollenbeck CB, Reaven GM: Relationship between resistance to insulin-mediated glucose uptake, urinary uric acid clearance, and plasma uric acid concentration. JAMA 1991, 266:3008-3011.
35. Galvan QA, Natali A, Baldi S, et al.: Effect of insulin on uric acid excretion in humans. Am J Physiol 1995, 268:E1-E5.
36. Muscelli E, Natali A, Bianchi S, et al.: Effect of insulin on renal sodium and uric acid handling in essential hypertension. Am J Hypertens 1996, 9:746-752.
37. Reaven GM: The kidney: an unwilling accomplice in syndrome X. Am J Kidney Dis 1997, 30:928-931.
38. Reaven G: Metabolic syndrome: pathophysiology and implications for management of cardiovascular disease. Circulation 2002, 106:286-288.
39. Xu H, Barnes GT, Yang Q, et al.: Chronic inflammation in fat plays a crucial role in the development of obesity-related insulin resistance. J Clin Invest 2003, 112:1821-1830.
40. Maalouf NM, Sakhaee K, Parks JH, et al.: Association of urinary pH with body weight in nephrolithiasis. Kidney Int 2004, 65:1422-1425.
41. Powell CR, Stoller ML, Schwartz BF, et al.: Impact of body weight on urinary electrolytes in urinary stone formers. Urology 2000, 55:825-830.
42. Siener R, Glatz S, Nicolay C, Hesse A: The role of overweight and obesity in calcium oxalate stone formation. Obes Res 2004, 12:106-113.
43. Taylor EN, Curhan GC: Body size and 24-hour urine composition. Am J Kidney Dis 2006, 48:905-915.
44. Hesse A, Classen A, Knoll M, et al.: Dependence of urine composition on the age and sex of healthy subjects. Clin Chim Acta 1986, 160:79-86.
45. Iozzo P, Beck-Nielsen H, Laakso M, et al.: Independent influence of age on basal insulin secretion in nondiabetic humans. European Group for the Study of Insulin Resistance. J Clin Endocrinol Metab 1999, 84:863-868.
46. Petersen KF, Befroy D, Dufour S, et al.: Mitochondrial dysfunction in the elderly: possible role in insulin resistance. Science 2003, 300:1140-1142.
47. Scuteri A, Najjar SS, Morrell CH, Lakatta EG: The metabolic syndrome in older individuals: prevalence and prediction of cardiovascular events: the Cardiovascular Health Study. Diabetes Care 2005, 28:882-887.
48. Johnson RJ, Segal MS, Srinivas T, et al.: Essential hypertension, progressive renal disease, and uric acid: a pathogenetic link? J Am Soc Nephrol 2005, 16:1909-1919.
49. Yoo TW, Sung KC, Shin HS, et al.: Relationship between serum uric acid concentration and insulin resistance and metabolic syndrome. Circ J 2005, 69:928-933.
50. Cohn GS, Kittleson MM, Blumenthal RS: Toward an improved diagnosis of the metabolic syndrome other clues to the presence of insulin resistance. Am J Hypertens 2005, 18:1099-1103.
51. Grundy SM, Hansen B, Smith SC Jr, et al.: Clinical management of metabolic syndrome: report of the American Heart Association/National Heart, Lung, and Blood Institute/American Diabetes Association conference on scientific issues related to management. Circulation 2004, 109:551-556.